|
Video: What is a Stock Split?
|
|
Cytek Biosciences is a cell analysis solutions company developing cell analysis tools by using technical approaches. Co. has developed and manufactured its full spectrum flow cytometry platform. Co.'s main instruments, the Aurora and Northern Lights systems, are the full spectrum flow cytometers able to deliver cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Co.'s Full Spectrum Profiling platform includes instruments, reagents, software, and services to provide an integrated suite of solutions for its customers. According to our Cytek BioSciences stock split history records, Cytek BioSciences has had 0 splits. | |
|
Cytek BioSciences (CTKB) has 0 splits in our Cytek BioSciences stock split history database.
Looking at the Cytek BioSciences stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cytek BioSciences shares, starting with a $10,000 purchase of CTKB, presented on a split-history-adjusted basis factoring in the complete Cytek BioSciences stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
07/26/2021 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$17.93 |
|
End price/share: |
$5.66 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-68.43% |
|
Average Annual Total Return: |
-34.27% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$3,156.64 |
|
Years: |
2.75 |
|
|
|
|
|